Aveanna Healthcare Holdings Inc risk profile
60 Stretched several inputs deteriorating together
Measured 21 October 2026 from AVAH's filed statements. Recomputed nightly.
60 (Stretched), driven by Concentration at 83, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 43 | Elevated | Volatile | One-year price volatility — 49.5% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 63 | Stretched | Easing | Interest cover — 1.91x |
| Competitive position | 47 | Elevated | Stable | Operating-margin gap against peers — +3.0 percentage points |
| Concentration | 83 | Acute | Stable | Customer concentration — 4,064 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Aveanna Healthcare Holdings Inc